Stock_Titan Posted - 2 days ago

$DGX Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests https://www.stocktitan.net/news/DGX/workforce-drug-test-cheating-surged-in-2023-finds-quest-diagnostics-4egiryu38aqy.html

Stock_Titan Posted - 4 days ago

$DGX Lab Week 2024 - Javarus Smith https://www.stocktitan.net/news/DGX/lab-week-2024-javarus-91ucymmn0zs2.html

Stock_Titan Posted - 1 week ago

$DGX Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI https://www.stocktitan.net/news/DGX/quest-diagnostics-to-acquire-path-ai-diagnostics-to-accelerate-ai-a4azirh6dint.html

Lectin_Pectin Posted - 2 weeks ago

$INBS very bullish article here. Great info and synopsis. https://talkmarkets.com/content/stocks--equities/intelligent-bio-solutions-fingerprint-drug-screening-technology-poised-for-massive-growth?post=442811 They might actually give those $LH and $DGX urine tests a run for their money!!

insiderbuyingselling Posted - 2 weeks ago

$DGX new insider selling: 1760 shares. http://insiderbuyingselling.com/?t=DGX

Stock_Titan Posted - 2 weeks ago

$DGX Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI https://www.stocktitan.net/news/DGX/quest-diagnostics-to-acquire-path-ai-diagnostics-to-accelerate-ai-egvwy1bi4n6n.html

Small_time_trader Posted - 04/30/24

$DGX little pop yesterday on FDA announcement on LDTs regulation… Little paradoxical but ruling will actually favor larger labs with a lot of established tests that will be considered grandfathered tests.

Stocksrunner Posted - 04/29/24

🏗️ Sector Spotlight: $DGX $LH - Quest Diagnostics, LabCorp climb following FDA testing oversight rule. Psychedelic drug developers could benefit from NIH funding for chronic pain.

Nelsin Posted - 04/29/24

$DGX Sell to Close for 10% Gain.

Stock_Titan Posted - 04/26/24

$DGX Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity https://www.stocktitan.net/news/DGX/quest-diagnostics-foundation-and-green-bronx-machine-expand-5wslk8abwepq.html

TalkMarkets Posted - 04/25/24

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth $INBS Also $ABT $DGX $LH $OSUR https://talkmarkets.com/content/stocks--equities/intelligent-bio-solutions-fingerprint-drug-screening-technology-poised-for-massive-growth?post=442811

TalkMarkets Posted - 04/25/24

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth $INBS Also $ABT $DGX $LH $OSUR https://talkmarkets.com/content/stocks--equities/intelligent-bio-solutions-fingerprint-drug-screening-technology-poised-for-massive-growth?post=442811

CrayP Posted - 04/25/24

$FLGT Even using the sale of $NVTAQ's distressed assets out of bankruptcy at 1X Sales would value $FLGT at $35 per share (including net cash). That's a minimum 40% Ming discount! Stop destroying value and sell the company to $LABC, $NEO or $DGX and use your proceeds to do whatever you want at your expense instead of the expense of shareholders! This company is not your personal piggy bank and the board has a fiduciary duty to all shareholders and not the largest.

Thestocktraderhubzee Posted - 04/25/24

WATCHLIST APR 25 2024. $AMZN JMP Securities Reiterates Market Outperform on Amazon.com, Maintains $225 Price Target $BX Argus Research Maintains Buy on Blackstone, Raises Price Target to $135 $WBS Citigroup Maintains Buy on Webster Finl, Lowers Price Target to $55 $DHR Citigroup Maintains Buy on Danaher, Raises Price Target to $290 $DGX Citigroup Maintains Neutral on Quest Diagnostics, Raises Price Target to $145

Stocksrunner Posted - 04/24/24

🎯 Target Price Updates 2/2: $CFG Citizens Financial stock target raised on solid performance. $DGX Quest Diagnostics stock target raised on strong performance. $PII Polaris stock target cut retains outperform rating on recent performance. https://stocksrunner.com/target

IN0V8 Posted - 04/24/24

$DGX Deutsche Bank raises target price to $136 from $125 Citigroup raises target price to $145 from $135 Evercore ISI raises target price to $145 from $140 Jefferies raises target price to $160 from $155 Mizuho raises target price to $155 from $150 Truist Securities raises target price to $150 from $145 UBS raises target price to $146 from $139

JackDarwin Posted - 04/23/24

$DGX Nice Gap Up With Good Volume.

Stocksrunner Posted - 04/23/24

🎯 Target Price Updates: $BHC RBC cuts target for Bausch Health shares due to Q1 results and BauschLomb spin-off. $BOWL Stifel lowers Bowlero stock target while maintaining buy rating. $GEVO maintains buy rating despite target price cut on strategic and financial update. $DGX sees target raised following a strong quarter. $DPZ anticipated to reveal Q1 results on April 29. Analysts suggest stock is undervalued. 🍕 https://stocksrunner.com/target

Small_time_trader Posted - 04/23/24

$DGX

DonCorleone77 Posted - 04/23/24

$DGX Quest Diagnostics raises FY24 adjusted EPS view $8.72-$8.97 from $8.60-$8.90 Consensus $8.75. Raises FY24 revenue view to $9.4B-$9.48B from $9.35B-$9.45B, consensus $9.4B. Backs FY24 capital expenditures view $420M. "In addition, our Invigorate initiative, which includes ongoing investments in automation and AI, continued to improve productivity as well as service levels and quality. Given the strength of our business, we are raising our revenue and adjusted earnings guidance for the full year," Davis said.

DonCorleone77 Posted - 04/23/24

$DGX Quest Diagnostics reports Q1 adjusted EPS $2.04, consensus $1.85 Reports Q1 revenue $2.37B, consensus $2.29B. "In the first quarter, we delivered nearly 6% base business revenue growth, continuing the strong momentum of recent quarters. We also grew total revenues for the first time since the height of the pandemic nearly three years ago," said Jim Davis, Chairman, CEO and President. "Our strong commercial focus on physicians and hospitals combined with our broad health plan access enabled us to take advantage of sustained high rates of healthcare utilization and drive new customer growth. Our investments within advanced diagnostics also enabled double digit growth within multiple key clinical areas, including brain health, women's health and advanced cardiometabolic health."

epsguid Posted - 04/23/24

$DGX reported earnings of $2.04, consensus was $1.86, Earnings Whisper was $1.88 via @eWhispers #whisperbeat http://eps.sh/d/dgx

Stock_Titan Posted - 04/23/24

$DGX Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 https://www.stocktitan.net/news/DGX/quest-diagnostics-reports-first-quarter-2024-financial-results-7p8dntbhcijv.html

DonCorleone77 Posted - 04/22/24

$DGX Quest Diagnostics launches blood biomarker test for Alzheimer's diagnosis Quest Diagnostics announced the launch of a new blood biomarker test for phosphorylated tau 217, or p-tau217. P-tau217 is a biomarker associated with Alzheimer's Disease, supported by research as useful for an early diagnosis of AD. The test is the latest addition to the AD-Detect portfolio of blood tests for assessing the risk of Alzheimer's Disease, which also includes testing for an array of AD biomarkers, including p-tau181 and amyloid beta proteins, as well as Apolipoprotein E isoform and plasma testing, for patients with cognitive impairment. The test is expected to be available for ordering on April 26.

Stock_Titan Posted - 04/22/24

$DGX Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease https://www.stocktitan.net/news/DGX/quest-diagnostics-adds-p-tau217-blood-biomarker-testing-to-suite-of-32wc7jcpgdwz.html

limitlist Posted - 1 month ago

$DGX Buying under 129.50. Very solid company that no one is talking about.

Stock_Titan Posted - 1 month ago

$DGX My Quest Story - Jessica Clow https://www.stocktitan.net/news/DGX/my-quest-story-jessica-y8i2tw6pcxyf.html

Aigner_Andreas Posted - 1 month ago

TD SELL $DGX at 132.29, Supp 127.12 Resis 134.77 R6 HiLo 51% T1Y 144 buy 2.5 DIV 1.85% #Quest Diag #stocks #trading #finance #market

Stock_Titan Posted - 1 month ago

$DGX Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay https://www.stocktitan.net/news/DGX/quest-diagnostics-and-broad-clinical-labs-to-evaluate-whole-genome-8t7grc0kfuje.html

Stock_Titan Posted - 1 month ago

$DGX My Quest Story - Pauline Chaves https://www.stocktitan.net/news/DGX/my-quest-story-pauline-1e3m1y243k3d.html